Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sara J. Schiller"'
Autor:
Westyn Branch-Elliman, Ryan Ferguson, Gheorghe Doros, Patricia Woods, Sarah Leatherman, Judith Strymish, Rupak Datta, Rekha Goswami, Matthew D Jankowich, Nishant R Shah, Thomas H Taylor, Sarah T Page, Sara J Schiller, Colleen Shannon, Cynthia Hau, Maura Flynn, Erika Holmberg, Karen Visnaw, Rupali Dhond, Mary Brophy, Paul A Monach
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263591 (2022)
Importance and objectiveThe aim of this pragmatic, embedded, adaptive trial was to measure the effectiveness of the subcutaneous anti-IL-6R antibody sarilumab, when added to an evolving standard of care (SOC), for clinical management of inpatients wi
Externí odkaz:
https://doaj.org/article/0f93913ce462481c84ad214cf1534dd7
Autor:
Samira Reyes Dassum, Ryan Ferguson, Patricia Woods, Maura Flynn, Karen Visnaw, Sara J Schiller, Paul Monach, Sarah Leatherman, Westyn Branch-Elliman
Publikováno v:
Open Forum Infectious Diseases. 9
Background Early in the COVID-19 pandemic, no evidence-proven therapeutics were approved, and thus participation in a clinical trial was often the only way to access experimental medications. However, in the US, participation in medical research is l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf8ecd129f11657ca3e294b0988da060
https://doi.org/10.1093/ofid/ofac492.906
https://doi.org/10.1093/ofid/ofac492.906
Autor:
Colleen Shannon, Grant D. Huang, Marjorie J. Good, Mary Brophy, Andrea Denicoff, Sara J. Schiller, Sheila A. Prindiville
Publikováno v:
Seminars in Oncology. 46:308-313
Cancer clinical trials represent an important option for patients with a diagnosis of cancer and the clinician-investigators involved in their care who seek options for their disease. For all who are impacted by cancer, these studies offer opportunit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1825f39110381bcc298d9ca4420af1eb
https://doi.org/10.1053/j.seminoncol.2019.09.005
https://doi.org/10.1053/j.seminoncol.2019.09.005
Autor:
Westyn Branch-Elliman, Ryan Ferguson, Gheorghe Doros, Patricia Woods, Sarah Leatherman, Judith Strymish, Rupak Datta, Rekha Goswami, Matthew D. Jankowich, Nishant R. Shah, Thomas H. Taylor, Sarah T. Page, Sara J. Schiller, Colleen Shannon, Cynthia Hau, Maura Flynn, Erika Holmberg, Karen Visnaw, Rupali Dhond, Mary Brophy, Paul A. Monach
Publikováno v:
PloS one. 17(2)
Importance and objective The aim of this pragmatic, embedded, adaptive trial was to measure the effectiveness of the subcutaneous anti-IL-6R antibody sarilumab, when added to an evolving standard of care (SOC), for clinical management of inpatients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b4f08d3d2cd527b9a600fdcfd71bd6
https://pubmed.ncbi.nlm.nih.gov/35213547
https://pubmed.ncbi.nlm.nih.gov/35213547